In vivo effects of the kavapyrones (+)-dihydromethysticin and (±)- kavain on dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5- hydroxyindoleacetic acid levels in striatal and cortical brain regions

Planta Medica

Volumn 64, Issue 6, 1998, Pages 507-510

  Boonen, G ^a   Ferger, B ^a   Kuschinsky, K ^a   Haberlein H ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Dihydromethysticin; Dopamine; Kava; Kavain; Piper methysticum; Piperaceae; Serotonin

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DIHYDROMETHYSTICIN; DOPAMINE; KAWAIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY NEUROSIS; ARTICLE; BRAIN CORTEX; DOPAMINE METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; RAT; SEROTONIN METABOLISM; STRIATE CORTEX;

ANIMALIA; PIPER METHYSTICUM; PIPERACEAE;

EID: 0031828928     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-957503     Document Type: Article

References (18)

1. Volz, H.-P., Kieser, M. (1997) Pharmacopsychiatry 30, 1-5.
2. Kretzschmar, R., Meyer, H. J., Teschendorf, H. J. (1970) Experientia 26, 283-284.
3. Meyer, H. J., Kretzschmar, R. (1966) Klin. Wochenschr. 44, 902-903.
4. Gleitz, J., Gottner, N., Ameri, A. (1996) Planta Med. 62, 580-581.
5. Gleitz, J., Friese, J., Beile, A., Ameri, A., Peters, T. (1996) Eur. J. Pharmacol. 315, 89-97.
6. Bundesanzeiger Nr. 101 vom 1.6.1990, monograph of the comission E.
7. Johnson, D., Frauendorf, A., Stecker, K., Stein, U. (1996) TW Neurologie Psychiatrie 5, 349-354.
8. Kinzler, E., Krömer, J., Lehmann, E. (1991) Arzneim.-Forsch./Drug Res. 41, 584-588.
9. Achenbach, H., Regel, W. (1973) Chem. Ber. 106, 2648-2653.
10. Häberlein, H., Boonen, G., Beck, M.-A. (1997) Planta Med. 63. 63-65.
11. Racagni, G., Masotto, C, Steardo, L. (1997) Pharmacology of Anxiolytic Drugs Hogrefe and Huber Publishers, Seattle, Toronto, Göttingen, Bern.
12. Wise, C D., Berger, B. D., Stein, L (1972) Science 177, 180-183.
13. Glaser, T., Traber, J. (1983) Eur. J. Pharmacol. 88, 137-138.
14. Baldessarini, R. J. (1996), in: Goodman and Gilman's The Pharmacological Basis of Therapeutics, (Hardman, J. G., Limbird, L E., eds.), pp. 399-430, McGraw-Hill. New York.
15. Di Chiara, G., Morelli, M., Acquas, E., Carboni, E. (1992) Arzneim.-Forsch./Drug Res. 42, 231-237.
16. Paykel, E. S. (1990). in: Pharmacology of Anxiolytic, (Racagni, G., Masotto, C., Steardo, L.), pp. x-xi, Seattle, Drugs Hogrefe and Huber Publishers, Toronto, Göttingen, Bern.
17. Seitz, U., Schüle, A., Gleitz, J. (1997) Planta Med. 63, 548-549.
18. Hapke, H. J., Sterner, W., Heisler, E., Bräuer, H. (1971) Il Farmaco - Ed. Pr. 26, 692-720.